Home / Companies / Swedish Orphan Biovitrum AB / 11 Dec 2024
Swedish Orphan Biovitrum AB: meeting of 11 Dec 2024
Votes reported on Form N-PX, item by item
87 Form N-PX filers reported votes at the Swedish Orphan Biovitrum AB meeting of 11 Dec 2024. Their records fall into 4 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
2 nominees; 94.2% of reported votes for; 4 filers withheld from or voted against at least one nominee.
252 vote records from 86 filers. 4 of the 77 filers that marked the item either way voted against management. 9 filers reported this item without a management mark.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
38 vote records from 17 filers. 0 of the 17 filers that marked the item either way voted against management.
CORPORATE GOVERNANCEIssuer
CORPORATE GOVERNANCE: management items
Management items in this category are shown together; filers word and number them differently.
992 vote records from 86 filers. 0 of the 77 filers that marked the item either way voted against management. 9 filers reported this item without a management mark.
OTHERIssuer
OTHER: management items
Management items in this category are shown together; filers word and number them differently.
189 vote records from 12 filers. 0 of the 1 filers that marked the item either way voted against management. 11 filers reported this item without a management mark.
How the largest families voted
| Family | 1. Directors | 2. Auditor |
|---|---|---|
| Vanguard | For | No report |
| BlackRock and iShares | For | For |
| Fidelity | Split or no vote | No report |
| State Street and SPDR | For | No report |
| American Century | For | No report |
| Franklin Templeton | For | No report |
| Invesco | For | No report |
| Equitable | For | No report |
| Charles Schwab | For | No report |
| Nuveen and TIAA | For | No report |
| John Hancock and Manulife | For | For |
| Morgan Stanley, Eaton Vance and Calvert | Against * | No report |
| J.P. Morgan | For | For |
| Goldman Sachs | Split or no vote | No report |
| PGIM and Prudential | For | No report |
| Jackson National funds | For | For |
| Northern Trust and FlexShares | Split or no vote | No report |
| T. Rowe Price | For | No report |
| Thrivent | For | No report |
| Lincoln Financial | For | No report |
| Voya | For | No report |
| First Trust | For | No report |
| Russell Investments | For | No report |
| Nationwide | For | No report |
| Victory Capital | For | No report |
| Brighthouse Funds | For | No report |
| BNY Mellon | For | No report |
| Principal | For | No report |
| Transamerica | For | No report |
| Federated Hermes | For | No report |
| AllianceBernstein | For | No report |
| Hartford Funds | For | No report |
| PIMCO | For | No report |
| Lord Abbett | For | No report |
| Artisan Partners | For | No report |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Swedish Orphan Biovitrum AB meeting?
87 Form N-PX filers reported votes at the meeting of 11 Dec 2024. The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Swedish Orphan Biovitrum AB on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Swedish Orphan Biovitrum AB
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Swedish Orphan Biovitrum AB with a meeting date within three days of 11 Dec 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.